Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Psychiatry
Published in: BMC Psychiatry 1/2014

Open Access 01-12-2014 | Research article

Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders

Authors: Maria Melchior, Elena Prokofyeva, Nadia Younès, Pamela J Surkan, Silvia S Martins

Published in: BMC Psychiatry | Issue 1/2014

Login to get access

Abstract

Background

Our aim was to examine whether comorbid mood and anxiety disorders influence patterns of treatment or the perceived unmet need for treatment among those not receiving treatment for illegal drug use disorders.

Methods

Data came from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC, 2001–2002 and 2004–2005, n = 34,653). Lifetime DSM-IV illegal drug use disorder (abuse and dependence), as well as comorbid mood (major depression, dysthymia, manic disorder, hypomanic disorder) and anxiety disorders (panic disorder, agoraphobia, social phobia, specific phobia, generalized anxiety) were ascertained by a standardized psychiatric interview. Treatment for illegal drug use disorders and perceived unmet need for treatment were assessed among individuals with illegal drug use disorder. Odds of treatment and odds of perceived unmet need for treatment were assessed using logistic regression, adjusting for socio-demographic characteristics, treatment for mood and anxiety disorders, and comorbid alcohol use disorder.

Results

Out of 34,653 participants, 1114 (3.2%) had a diagnosis of lifetime illegal drug use disorder: 21.2% had a comorbid mood disorder only, 11.8% a comorbid anxiety disorder only, and 45.9% comorbid mood and anxiety disorders. Comorbid mood and anxiety disorders were not related to treatment for illegal drug use disorders but were associated with an elevated likelihood of unmet need for treatment: compared to participants with no comorbidities, multivariate ORs were 2.21 (95% CI: 1.23- 4.10) for mood disorder only, 2.38 (95% CI: 1.27-4.45) for anxiety disorder only, and 2.90 (95% CI: 1.71-4.94) for both mood and anxiety disorders.

Conclusions

Individuals with an illegal drug use disorder and comorbid mood or anxiety disorders are disproportionately likely to report unmet need for treatment. Integrated mental health and substance use programs could prove effective in addressing their treatment needs.
Literature
1.
Compton WM, Thomas YF, Stinson FS, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007, 64: 566-576. 10.1001/archpsyc.64.5.566.CrossRefPubMed
2.
Regier DA, Farmer ME, Rae DS, Locke BZ, Keith SJ, Judd LL, Goodwin FK: Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990, 264: 2511-2518. 10.1001/jama.1990.03450190043026.CrossRefPubMed
3.
Dickey B, Normand SL, Weiss RD, Drake RE, Azeni H: Medical morbidity, mental illness, and substance use disorders. Psychiatr Serv. 2002, 53: 861-867.CrossRefPubMed
4.
Watkins KE, Hunter SB, Wenzel SL, Tu W, Paddock SM, Griffin A, Ebener P: Prevalence and characteristics of clients with co-occurring disorders in outpatient substance abuse treatment. Am J Drug Alcohol Abuse. 2004, 30: 749-764. 10.1081/ADA-200037538.CrossRefPubMed
5.
Watkins KE, Burnam A, Kung FY, Paddock S: A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatr Serv. 2001, 52: 1062-1068. 10.1176/appi.ps.52.8.1062.CrossRefPubMed
6.
McFarland BH, Gabriel RM: Datapoints: service availability for persons with co-occurring conditions. Psychiatr Serv. 2004, 55: 978-10.1176/appi.ps.55.9.978.CrossRefPubMed
7.
Grant BF, Hasin DS, Stinson FS, Dawson DA, Goldstein RB, Smith S, Huang B, Saha TD: The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry. 2006, 67: 363-374. 10.4088/JCP.v67n0305.CrossRefPubMed
8.
Grant BF, Hasin DS, Stinson FS, Dawson DA, June RW, Goldstein RB, Smith SM, Saha TD, Huang B: Prevalence, correlates, co-morbidity, and comparative disability of DSM-IV generalized anxiety disorder in the USA: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychol Med. 2005, 35: 1747-1759. 10.1017/S0033291705006069.CrossRefPubMed
9.
Hasin DS, Goodwin RD, Stinson FS, Grant BF: Epidemiology of major depressive disorder: results from the national epidemiologic survey on alcoholism and related conditions. Arch Gen Psychiatry. 2005, 62: 1097-1106. 10.1001/archpsyc.62.10.1097.CrossRefPubMed
10.
Hasin DS, Stinson FS, Ogburn E, Grant BF: Prevalence, correlates, disability, and comorbidity of DSM-IV alcohol abuse and dependence in the united states: results from the national epidemiologic survey on alcohol and related conditions. Arch Gen Psychiatry. 2007, 64: 830-842. 10.1001/archpsyc.64.7.830.CrossRefPubMed
11.
Martins SS, Gorelick DA: Conditional substance abuse and dependence by diagnosis of mood or anxiety disorder or schizophrenia in the U.S. Population. Drug Alcohol Depend. 2011, 119: 28-36. 10.1016/j.drugalcdep.2011.05.010.CrossRefPubMedPubMedCentral
12.
Mackenzie CS, Reynolds K, Cairney J, Streiner DL, Sareen J: Disorder-specific mental health service use for mood and anxiety disorders: associations with age, sex, and psychiatric comorbidity. Depress Anxiety. 2012, 29: 234-242. 10.1002/da.20911.CrossRefPubMed
13.
Mericle AA, Belenko S, Festinger DS: Detection, advice, and referral to services (DARTS) procedures among clients with public defenders. Subst Use Misuse. 2011, 46: 1734-1744. 10.3109/10826084.2011.618997.CrossRefPubMed
14.
Cook BL, Alegria M: Racial-ethnic disparities in substance abuse treatment: the role of criminal history and socioeconomic status. Psychiatr Serv. 2011, 62: 1273-1281.CrossRefPubMedPubMedCentral
15.
Bouchery EE, Harwood HJ, Dilonardo J, Vandivort-Warren R: Type of health insurance and the substance abuse treatment gap. J Subst Abuse Treat. 2012, 42: 289-300. 10.1016/j.jsat.2011.09.002.CrossRefPubMed
16.
Elhai JD, Ford JD: Correlates of mental health service use intensity in the national comorbidity survey and national comorbidity survey replication. Psychiatr Serv. 2007, 58: 1108-1115. 10.1176/appi.ps.58.8.1108.CrossRefPubMed
17.
Harris KM, Edlund MJ: Use of mental health care and substance abuse treatment among adults with co-occurring disorders. Psychiatr Serv. 2005, 56: 954-959. 10.1176/appi.ps.56.8.954.CrossRefPubMed
18.
Grella CE, Karno MP, Warda US, Moore AA, Niv N: Perceptions of need and help received for substance dependence in a national probability survey. Psychiatr Serv. 2009, 60: 1068-1074.CrossRefPubMedPubMedCentral
19.
Green-Hennessy S: Factors associated with receipt of behavioral health services among persons with substance dependence. Psychiatr Serv. 2002, 53: 1592-1598. 10.1176/appi.ps.53.12.1592.CrossRefPubMed
20.
Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC: Twelve-month use of mental health services in the united states: results from the national comorbidity survey replication. Arch Gen Psychiatry. 2005, 62: 629-640. 10.1001/archpsyc.62.6.629.CrossRefPubMed
21.
Wu LT, Ringwalt CL, Williams CE: Use of substance abuse treatment services by persons with mental health and substance use problems. Psychiatr Serv. 2003, 54: 363-369.CrossRefPubMed
22.
Kessler RC, Nelson CB, McGonagle KA, Edlund MJ, Frank RG, Leaf PJ: The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry. 1996, 66: 17-31.CrossRefPubMed
23.
Wu LT, Kouzis AC, Leaf PJ: Influence of comorbid alcohol and psychiatric disorders on utilization of mental health services in the national comorbidity survey. Am J Psychiatr. 1999, 156: 1230-1236.PubMed
24.
Mojtabai R, Olfson M, Mechanic D: Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders. Arch Gen Psychiatry. 2002, 59: 77-84. 10.1001/archpsyc.59.1.77.CrossRefPubMed
25.
National Institute on Alcohol Abuse and Alcoholism: Alcohol use and alcohol use disorders in the United States: main findings from the 2001–2002 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Alcohol Epidemiologic Data Reference Manual. 2006, Bethesda, MD: NIH
26.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 1994, Washington, DC: American Psychological Association, 4
27.
Krauke F, Valliant R: A Survey on survey statistics: What is done and can be done in Stata. Stata J. 2007, 7: 1-21.
28.
Kessler RC, Angermeyer M, Anthony JC, de Graaf R, Demyttenaere K, Gasquet I, DE Girolamo G, Gluzman S, Gureje O, Haro JM, Kawakami N, Karam A, Levinson D, Medina Mora ME, Oakley Browne MA, Posada-Villa J, Stein DJ, Adley Tsang CH, Aguilar-Gaxiola S, Alonso J, Lee S, Heeringa S, Pennell BE, Berglund P, Gruber MJ, Petukhova M, Chatterji S, Ustün TB: Lifetime prevalence and age-of-onset distributions of mental disorders in the World Health Organization’s world mental health survey initiative. World Psychiatry. 2007, 6: 168-176.PubMedPubMedCentral
29.
Fenton MC, Keyes KM, Martins SS, Hasin DS: The role of a prescription in anxiety medication use, abuse, and dependence. Am J Psychiatr. 2010, 167: 1247-1253. 10.1176/appi.ajp.2010.09081132.CrossRefPubMedPubMedCentral
30.
Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP: The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995, 39: 37-44. 10.1016/0376-8716(95)01134-K.CrossRefPubMed
31.
Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R: The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003, 71: 7-16. 10.1016/S0376-8716(03)00070-X.CrossRefPubMed
32.
Mojtabai R, Crum RM: Perceived unmet need for alcohol and drug use treatments and future use of services: results from a longitudinal study. Drug Alcohol Depend. 2013, 127: 59-64. 10.1016/j.drugalcdep.2012.06.012.CrossRefPubMed
33.
Fucito L, Gomes B, Murnion B, Haber P: General practitioners’ diagnostic skills and referral practices in managing patients with drug and alcohol-related health problems: implications for medical training and education programmes. Drug Alcohol Rev. 2003, 22: 417-424. 10.1080/09595230310001613930.CrossRefPubMed
34.
Babor TF, Kadden RM: Screening and interventions for alcohol and drug problems in medical settings: what works?. J Trauma. 2005, 59: S80-S87. 10.1097/01.ta.0000174664.88603.21.CrossRefPubMed
35.
McLellan AT, Meyers K: Contemporary addiction treatment: a review of systems problems for adults and adolescents. Biol Psychiatry. 2004, 56: 764-770. 10.1016/j.biopsych.2004.06.018.CrossRefPubMed
36.
McGovern MP, Clark RE, Samnaliev M: Co-occurring psychiatric and substance use disorders: a multistate feasibility study of the quadrant model. Psychiatr Serv. 2007, 58: 949-954. 10.1176/appi.ps.58.7.949.CrossRefPubMed
37.
Sacks S, Chaple M, Sirikantraporn J, Sacks JY, Knickman J, Martinez J: Improving the capability to provide integrated mental health and substance abuse services in a state system of outpatient care. J Subst Abuse Treat. 2013, 44: 488-493. 10.1016/j.jsat.2012.11.001.CrossRefPubMed
38.
Sacks S, McKendrick K, Sacks JY, Cleland CM: Modified therapeutic community for co-occurring disorders: single investigator meta analysis. Subst Abus. 2010, 31: 146-161. 10.1080/08897077.2010.495662.CrossRefPubMedPubMedCentral
39.
Sacks S, McKendrick K, Sacks JY, Banks S, Harle M: Enhanced outpatient treatment for co-occurring disorders: main outcomes. J Subst Abuse Treat. 2008, 34: 48-60. 10.1016/j.jsat.2007.01.009.CrossRefPubMed
40.
Burnam MA, Watkins KE: Substance abuse with mental disorders: specialized public systems and integrated care. Health Aff. 2006, 25: 648-658. 10.1377/hlthaff.25.3.648.CrossRef
41.
Hoge MA, Paris M, Adger H, Collins FL, Finn CV, Fricks L, Gill KJ, Haber J, Hansen M, Ida DJ, Kaplan L, Northey WF, O'Connell MJ, Rosen AL, Taintor Z, Tondora J, Young AS: Workforce competencies in behavioral health: an overview. Adm Policy Ment Health. 2005, 32: 593-631. 10.1007/s10488-005-3259-x.CrossRefPubMed
42.
Woltmann EM, Whitley R, McHugo GJ, Brunette M, Torrey WC, Coots L, Lynde D, Drake RE: The role of staff turnover in the implementation of evidence-based practices in mental health care. Psychiatr Serv. 2008, 59: 732-737. 10.1176/appi.ps.59.7.732.CrossRefPubMed
43.
Sussman S, Valente TW, Rohrbach LA, Skara S, Pentz MA: Translation in the health professions: converting science into action. Eval Health Prof. 2006, 29: 7-32. 10.1177/0163278705284441.CrossRefPubMed
44.
Gotham HJ, Brown JL, Comaty JE, McGovern MP, Claus RE: Assessing the co-occurring capability of mental health treatment programs: the Dual Diagnosis Capability in Mental Health Treatment (DDCMHT) Index. J Behav Health Serv Res. 2013, 40: 234-241. 10.1007/s11414-012-9317-8.CrossRefPubMed
45.
Gotham HJ, Claus RE, Selig K, Homer AL: Increasing program capability to provide treatment for co-occurring substance use and mental disorders: organizational characteristics. J Subst Abuse Treat. 2010, 38: 160-169. 10.1016/j.jsat.2009.07.005.CrossRefPubMed
46.
Matthews H, Kelly PJ, Deane FP: The dual diagnosis capability of residential addiction treatment centres: priorities and confidence to improve capability following a review process. Drug Alcohol Rev. 2011, 30: 195-199. 10.1111/j.1465-3362.2010.00215.x.CrossRefPubMed
47.
McGovern MP, Lambert-Harris C, Gotham HJ, Claus RE, Xie H: Dual diagnosis capability in mental health and addiction treatment services: an assessment of programs across multiple state systems. Adm Policy Ment Health. 2012, 2: 205-214.
Metadata
Title
Treatment for illegal drug use disorders: the role of comorbid mood and anxiety disorders
Authors
Maria Melchior
Elena Prokofyeva
Nadia Younès
Pamela J Surkan
Silvia S Martins
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Psychiatry / Issue 1/2014
Electronic ISSN: 1471-244X
DOI
https://doi.org/10.1186/1471-244X-14-89

Other articles of this Issue 1/2014

BMC Psychiatry 1/2014 Go to the issue

Research article

Alterations in circadian/seasonal rhythms and vegetative functions are related to suicidality in DSM-5 PTSD

Research article

Theory of mind and neurocognition in early psychosis: a quasi-experimental study

Research article

Risk stratification using data from electronic medical records better predicts suicide risks than clinician assessments

Research article

Adult attention-deficit/hyperactivity disorder and nicotine use: a qualitative study of patient perceptions

Research article

Antipsychotic patterns of use in patients with schizophrenia: polypharmacy versus monotherapy

Research article

The association of ADHD symptoms to self-harm behaviours: a systematic PRISMA review